Figure S1 from ADAM Metallopeptidase Domain 12 Facilitates Colorectal Cancer Progression by Inhibiting Hippo Signaling Pathway Activity

Figure S1. The correlation analysis between ADAM12 and YAP1.(A) The correlation analysis between ADAM12 and YAP1 in CRC based on the TCGA-COAD data. (B) The correlation analysis between ADAM12 and YAP1 in CRC patients. (C) CRC patients with high YAP1 expression showed markedly lower 2000-days survival than those with low YAP1 expression. (D) Western blot analysis of ADAM12 in T84 cells with YAP1 knockdown.